|

Update on HIV and SARS-CoV-2: Hybrid Symposium

Chapters

  • Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium
  • Nathan Clumeck, Saint-Pierre University Hospital-ULB , Brussels, Belgium
  • Bart Lambrecht, Ghent University, Ghent, Belgium
  • Hanneke Schuitemaker, Amsterdam University Medical Center, Amsterdam, NL
Start module
  • Johan Neyts, KU Leuven, Leuven, Belgium
  • Xavier Saelens, VIB and Ghent University, Ghent, Belgium
  • Lieven Annemans, Ghent University and Brussels University (VUB), Belgium
Start module
  • Mathias Lichterfeld, Harvard Medical School, Boston, US
  • Basiel Cole, Ghent University, Ghent, Belgium
  • Robert Siliciano, Johns Hopkins University, Maryland, US
Start module
  • Lucy Dorrell, University of Oxford, Oxford, UK
  • Susan Ribeiro, Case Western Reserve University, Cleveland, US
  • Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium
Start module

Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium

Start module

Panel

Linos Vandekerckhove

Linos Vandekerckhove

Head of the HIV Cure Research Center, UZ Gent

Bart Lambrecht

Bart Lambrecht

Ghent University, Ghent, Belgium

 

 

Susan Pereira Ribeiro

Susan Pereira Ribeiro

Case Western Reserve University, Cleveland, US

 

 

Johan Neyts

Johan Neyts

Departement Microbiologie, Immunologie en Transplantatie UZ Leuven

 

 

Xavier Saelens

Xavier Saelens

Group Leader at the VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium

 

 

Lieven Annemans

Lieven Annemans

Ghent University and Brussels University (VUB), Ghent, Belgium

 

 

Basiel Cole

Basiel Cole

PhD Student, HIV Cure Research Center, Ghent University

 

 

Mathias Lichterfeld

Mathias Lichterfeld

Harvard Medical School, Boston, US

 

 

Robert Siliciano

Robert Siliciano

Johns Hopkins University, Maryland, US

 

 

Lucy Dorrell

Lucy Dorrell

University of Oxford, Oxford, UK

 

 

Nathan Clumeck

Nathan Clumeck

UMC Sint-Pieter, Brussels, Belgium

 

 

Gilles Darcis

Gilles Darcis

(Chair) CHU Liège

 

 

Kevin Arïen

Kevin Arïen

(Chair) ITG

 

 

Steven Callens

Steven Callens

(Chair) Diensthoofd Algemene inwendige ziekten UZ Gent

 

 

Sarah Gerlo

Sarah Gerlo

(Chair) Ghent University, Ghent, Belgium

 

 

Wojciech Witkowski

Wojciech Witkowski

(Chair) Ghent University, Ghent, Belgium

 

 

Marion Pardons

Marion Pardons

(Chair), Ghent University, Belgium

 

 

Guido Vanham

Guido Vanham

Hanneke Schuitemaker

Hanneke Schuitemaker

Janssen Pharmaceuticals, Leiden, Netherlands

 

 

Chapters

  • Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium
  • Nathan Clumeck, Saint-Pierre University Hospital-ULB , Brussels, Belgium
  • Bart Lambrecht, Ghent University, Ghent, Belgium
  • Hanneke Schuitemaker, Amsterdam University Medical Center, Amsterdam, NL
Start module
  • Johan Neyts, KU Leuven, Leuven, Belgium
  • Xavier Saelens, VIB and Ghent University, Ghent, Belgium
  • Lieven Annemans, Ghent University and Brussels University (VUB), Belgium
Start module
  • Mathias Lichterfeld, Harvard Medical School, Boston, US
  • Basiel Cole, Ghent University, Ghent, Belgium
  • Robert Siliciano, Johns Hopkins University, Maryland, US
Start module
  • Lucy Dorrell, University of Oxford, Oxford, UK
  • Susan Ribeiro, Case Western Reserve University, Cleveland, US
  • Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium
Start module

Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium

Start module